These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37961394)

  • 1. Lac-Phe mediates the anti-obesity effect of metformin.
    Xiao S; Li VL; Lyu X; Chen X; Wei W; Abbasi F; Knowles JW; Deng S; Tiwari G; Shi X; Zheng S; Farrell L; Chen ZZ; Taylor KD; Guo X; Goodarzi MO; Wood AC; Ida Chen YD; Lange LA; Rich SS; Rotter JI; Clish CB; Tahir UA; Gerszten RE; Benson MD; Long JZ
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lac-Phe mediates the effects of metformin on food intake and body weight.
    Xiao S; Li VL; Lyu X; Chen X; Wei W; Abbasi F; Knowles JW; Tung AS; Deng S; Tiwari G; Shi X; Zheng S; Farrell L; Chen ZZ; Taylor KD; Guo X; Goodarzi MO; Wood AC; Chen YI; Lange LA; Rich SS; Rotter JI; Clish CB; Tahir UA; Gerszten RE; Benson MD; Long JZ
    Nat Metab; 2024 Apr; 6(4):659-669. PubMed ID: 38499766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-10, cis-12 conjugated linoleic acid- and caloric restriction-mediated upregulation of CNDP2 expression in white adipose tissue in rodents, with implications in feeding and obesity.
    Berkel C; Cacan E
    J Nutr Biochem; 2023 Apr; 114():109269. PubMed ID: 36641073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exercise-inducible metabolite that suppresses feeding and obesity.
    Li VL; He Y; Contrepois K; Liu H; Kim JT; Wiggenhorn AL; Tanzo JT; Tung AS; Lyu X; Zushin PH; Jansen RS; Michael B; Loh KY; Yang AC; Carl CS; Voldstedlund CT; Wei W; Terrell SM; Moeller BC; Arthur RM; Wallis GA; van de Wetering K; Stahl A; Kiens B; Richter EA; Banik SM; Snyder MP; Xu Y; Long JZ
    Nature; 2022 Jun; 606(7915):785-790. PubMed ID: 35705806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC17 transporters mediate renal excretion of Lac-Phe in mice and humans.
    Li VL; Xiao S; Schlosser P; Scherer N; Wiggenhorn AL; Spaas J; Tung AS; Karoly ED; Köttgen A; Long JZ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
    Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin's Impact on the Microvascular Response to Insulin.
    Love KM; Barrett EJ; Horton WB
    Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36201598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
    Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
    Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
    Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
    Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
    Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACAD10 is not required for metformin's metabolic actions or for maintenance of whole-body metabolism in C57BL/6J mice.
    Yew MJ; Heywood SE; Ng J; West OM; Pal M; Kueh A; Lancaster GI; Myers S; Yang C; Liu Y; Reibe S; Mellett NA; Meikle PJ; Febbraio MA; Greening DW; Drew BG; Henstridge DC
    Diabetes Obes Metab; 2024 May; 26(5):1731-1745. PubMed ID: 38351663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
    Martin-Castillo B; Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
    Cell Cycle; 2010 Mar; 9(6):1057-64. PubMed ID: 20305377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate.
    McCarty MF
    Med Hypotheses; 1999 Feb; 52(2):89-93. PubMed ID: 10340287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77).
    Venu VKP; Saifeddine M; Mihara K; Faiza M; Gorobets E; Flewelling AJ; Derksen DJ; Hirota SA; Marei I; Al-Majid D; Motahhary M; Ding H; Triggle CR; Hollenberg MD
    Mol Pharmacol; 2021 Nov; 100(5):428-455. PubMed ID: 34452975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
    Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans.
    Scott B; Day EA; O'Brien KL; Scanlan J; Cromwell G; Scannail AN; McDonnell ME; Finlay DK; Lynch L
    Nat Metab; 2024 Apr; 6(4):651-658. PubMed ID: 38499765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
    Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
    Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway.
    Chen X; Ma J; Yao Y; Zhu J; Zhou Z; Zhao R; Dong X; Gao W; Zhang S; Huang S; Chen L
    Int Immunopharmacol; 2021 Jul; 96():107771. PubMed ID: 34004440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells.
    Park D
    Biol Pharm Bull; 2019; 42(12):2002-2008. PubMed ID: 31787716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
    Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
    Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.